GE Healthcare (GE) Updates on Results from Two Phase 3s of [18F]flutemetamol

Go back to GE Healthcare (GE) Updates on Results from Two Phase 3s of [18F]flutemetamol
General Electric (NYSE: GE) Delayed: 344.64 --0 (-0%)
Previous Close $344.64    52 Week High $33.00 
Open $344.64    52 Week Low $27.10 
Day High $344.64    P/E 234.45 
Day Low $344.64    EPS $1.47 
Volume 11,264